This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saxena, N. K. Articles by Anania, F. A. Search for Related Content PubMed PubMed Citation Articles by Saxena, N. K. Articles by Anania, F. A.

Concomitant Activation of the JAK/STAT, PI3K/AKT, and ERK Signaling Is Involved in Leptin-Mediated Promotion of Invasion and Migration of Hepatocellular Carcinoma Cells

¹ Division of Digestive Diseases, Department of Medicine and ² Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia and ³ Dipartimento di Medicina Interna University of Florence, Florence, Italy

Requests for reprints: Frank A. Anania, Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Room 248, 615 Michael Street, Atlanta, GA 30322. Phone: 404-712-2867; Fax: 404-721-2980; E-mail: fanania{at}emory.edu.

Various epidemiologic studies have shown that obesity is associated with hepatocellular carcinoma. Leptin, the key player in the regulation of energy balance and body weight control, also acts as a growth factor on certain organs in both normal and disease states. It is plausible that leptin acts to promote hepatocellular carcinogenesis directly affecting malignant properties of liver cancer cells. However, a direct role for leptin in hepatocellular carcinoma has not been shown. In this study, we analyzed the role of leptin and the mechanism(s) underlying its action in hepatocellular carcinoma cells, which express both short and long isoforms of leptin receptors. Treatment with leptin resulted in increased proliferation of both HepG2 and Huh7 cells and involves activation of signal transducers and activators of transcription 3 (STAT3), AKT, and extracellular signal-regulated kinase (ERK) signaling pathways. Leptin-induced phosphorylation of ERK and AKT was dependent on Janus-activated kinase (JAK)/STAT activation. Intriguingly, we also found that leptin potently induces invasion of hepatocellular carcinoma cells in Matrigel invasion and electric cell-substrate impedance-sensing assays. Leptin-stimulated invasion was effectively blocked by pharmacologic inhibitors of JAK/STAT and, to a lesser extent, by ERK and phosphatidylinositol 3-kinase (PI3K) inhibition. Importantly, leptin also induced the migration of both HepG2 and Huh7 cells on fibronectin matrix. Inhibition of JAK/STAT, ERK, and PI3K activation using pharmacologic inhibitors effectively blocked leptin-induced migration of HepG2 and Huh7 cells. Taken together, these data indicate that leptin promotes hepatocellular carcinoma growth, invasiveness, and migration and implicate the JAK/STAT pathway as a critical mediator of leptin action. Our findings have potential clinical implications for hepatocellular carcinoma progression in obese patients. [Cancer Res 2007;67(6):2497–507]

This article has been cited by other articles:

				N. Bergelin, T. Blom, J. Heikkila, C. Lof, C. Alam, S. Balthasar, J. P. Slotte, A. Hinkkanen, and K. Tornquist Sphingosine Kinase as an Oncogene: Autocrine Sphingosine 1-Phoshate Modulates ML-1 Thyroid Carcinoma Cell Migration by a Mechanism Dependent on Protein Kinase C-{alpha} and ERK1/2 Endocrinology, May 1, 2009; 150(5): 2055 - 2063. [Abstract] [Full Text] [PDF]

				S.-N. Yang, H.-T. Chen, H.-K. Tsou, C.-Y. Huang, W.-H. Yang, C.-M. Su, Y.-C. Fong, W.-P. Tseng, and C.-H. Tang Leptin enhances cell migration in human chondrosarcoma cells through OBRl leptin receptor Carcinogenesis, April 1, 2009; 30(4): 566 - 574. [Abstract] [Full Text] [PDF]

				N. K. Saxena, L. Taliaferro-Smith, B. B. Knight, D. Merlin, F. A. Anania, R. M. O'Regan, and D. Sharma Bidirectional Crosstalk between Leptin and Insulin-like Growth Factor-I Signaling Promotes Invasion and Migration of Breast Cancer Cells via Transactivation of Epidermal Growth Factor Receptor Cancer Res., December 1, 2008; 68(23): 9712 - 9722. [Abstract] [Full Text] [PDF]

				G. Fava, G. Alpini, C. Rychlicki, S. Saccomanno, S. DeMorrow, L. Trozzi, C. Candelaresi, J. Venter, A. Di Sario, M. Marzioni, et al. Leptin Enhances Cholangiocarcinoma Cell Growth Cancer Res., August 15, 2008; 68(16): 6752 - 6761. [Abstract] [Full Text] [PDF]

				V. Bartella, S. Cascio, E. Fiorio, A. Auriemma, A. Russo, and E. Surmacz Insulin-Dependent Leptin Expression in Breast Cancer Cells Cancer Res., June 15, 2008; 68(12): 4919 - 4927. [Abstract] [Full Text] [PDF]

				B. Mattioli, E. Straface, P. Matarrese, M. G. Quaranta, L. Giordani, W. Malorni, and M. Viora Leptin as an immunological adjuvant: enhanced migratory and CD8+ T cell stimulatory capacity of human dendritic cells exposed to leptin FASEB J, June 1, 2008; 22(6): 2012 - 2022. [Abstract] [Full Text] [PDF]

				T. Ozbay and R. Nahta A Novel Unidirectional Cross-Talk from the Insulin-Like Growth Factor-I Receptor to Leptin Receptor in Human Breast Cancer Cells Mol. Cancer Res., June 1, 2008; 6(6): 1052 - 1058. [Abstract] [Full Text] [PDF]

				B. Chung, P. Matak, A. T. McKie, and P. Sharp Leptin Increases the Expression of the Iron Regulatory Hormone Hepcidin in HuH7 Human Hepatoma Cells J. Nutr., November 1, 2007; 137(11): 2366 - 2370. [Abstract] [Full Text] [PDF]